About

MEET THE TEAM

wILLIAM coLton

William founded Paldara to develop a thermostable bacteriophage-embedded hydrogel platform addressing critical unmet needs in human, veterinary, and environmental health, and he leads the company’s scientific strategy, partnerships, and capital formation.

CEO & Founder

Barbara Marusiak

Experienced executive and advisor with a background in life sciences operations and strategy, supporting Paldara’s organizational growth and external engagement.

Advisor

Chad Johnson, JD

Legal and strategic advisor to Paldara Pharmaceuticals, providing guidance on corporate governance, intellectual property strategy, and transactional matters as the company advances its platform technology toward commercialization.

Lead Designer

Jacob Miller

Chief Financial Officer supports Paldara’s research and operational initiatives, contributing to laboratory execution, data analysis, and project coordination across the company’s development programs

Marketing Lead

Dr. Josh Nickols

Scientist with expertise in microbiology and translational research, contributing scientific insight to Paldara’s development and validation efforts.

Advisor

Dr. Roscoe Moore, Jr.

Globally recognized public health leader with extensive experience at the Centers for Disease Control and Prevention and the World Health Organization. He advises Paldara on global health strategy, infectious disease preparedness, and policy-relevant deployment of antimicrobial technologies.

Board Advisor

Dr. Mark Mani, MD

Physician-scientist and entrepreneur with experience in clinical innovation and healthcare technology development. He advises Paldara on clinical relevance, translational pathways, and market alignment.

Surgical and Operative Lead

General Kevin Leonard

Retired U.S. Army General with decades of leadership experience in defense, logistics, and national security. He advises Paldara on operational resilience, government engagement, and dual-use applications of its platform technologies.

Board Advisor

Dr. Elaine Hamm

A founder and researcher with experience in infectious diseases and patient-centered care. She supports Paldara’s efforts to align its technologies with real-world clinical needs.

Advisor

Penny Hawkins

Research Administration professional with 22+ years of experience. She assists the CEO with Administrative tasks as well as managing Research Administration.

Executive Assistant/Research Administration Manager

Dr. Khadija Belhassan

Scientist and innovator with expertise spanning molecular biology, translational research, and global health initiatives. She advises Paldara on scientific strategy and international collaboration.

Chief Science Officer

Advancing targeted therapies for antimicrobial resistance

PALDARA is a biotechnology company developing next-generation bacteriophage therapeutics and advanced biomaterial delivery platforms. Our work is focused on highly targeted approaches designed to help prevent and treat multidrug-resistant infections while reducing reliance on traditional antibiotics.

Explore Research

Built on science and purpose

Our story is rooted in the urgent need for new antibacterial strategies. PALDARA combines bacteriophage science with biomaterial innovation to create delivery systems that are precise, adaptable, and designed for real clinical impact.

Scientists discussing research findings in a modern biotechnology laboratory

Mission

Target the infection source

We are developing therapies that harness bacteriophages to address bacterial infections with specificity, supporting a more focused therapeutic approach in the era of antimicrobial resistance.

Precision-driven design

Phage-based innovation

AMR-focused development

Platform

Engineer smarter delivery

Our proprietary phage-hydrogel platform is designed to protect and localize therapeutic activity, helping improve delivery where targeted antibacterial action is needed most.

Biomaterial integration

Localized application

Scalable platform potential

Scientist working with laboratory equipment in a biotechnology setting

Research team in discussion around a table

Vision

Translate research into impact

We aim to bridge rigorous discovery with translational development, building a pipeline that supports future partnerships, clinical progress, and meaningful advances in infection care.

Translational mindset

Partnership ready

Patient-centered outcomes

Leadership and expertise

PALDARA brings together scientific, translational, and strategic perspectives to advance novel anti-infective solutions. Our team is united by a commitment to rigorous research, responsible innovation, and measurable therapeutic progress.